✦ LIBER ✦

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

✍ Scribed by LloydE. Damon; LauraJ. Johnston; CurtA. Ries; HopeS. Rugo; Delvyn Case; Kenneth Ault; CharlesA. Linker

Book ID: 105991919
Publisher: Springer
Year: 2004
Tongue: English
Weight: 199 KB
Volume: 53
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-003-0758-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of treatment with an intensive i

Results of treatment with an intensive induction regimen using idarubicin in combination with cytarabine and etoposide in children with acute myeloblastic leukemia

✍ Federico Sackmann-Muriel; Pedro Zubizarreta; María Sara Felice; Guillermo Chanta 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 911 KB

Treatment of acute leukemia arising from

Treatment of acute leukemia arising from myelodysplastic syndromes with oral idarubicin, etoposide, and 6-thioguanine

✍ M. Montillo; A. Tedeschi; A. Olivieri; R. Centurioni; G. Pelliccia; G. Marchegia 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Amsacrine, cytarabine and etoposide in t

Amsacrine, cytarabine and etoposide in the treatment of bad prognosis acute myeloid leukemia

✍ Anders Wahlin 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 463 KB

Remission induction therapy of untreated

Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin

✍ Eric J. Bow; Gilles Gallant; Gaynor J. Williams; Donna Woloschuk; Tsiporah B. Sh 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

## BACKGROUND. The safety and efficacy of idarubicin, etoposide, and carboplatin as remission induction therapy for patients younger than 60 years with untreated acute myeloid leukemia was studied as an alternative to standard regimens based on cytarabine plus anthracycline. ## METHODS. Eligibl

Population pharmacokinetics of cytarabin

Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia

✍ Mikkel Krogh-Madsen; Brendan Bender; Morten Krogh Jensen; Ove Juul Nielsen; Lena 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 346 KB

Intensive chemotherapy with idarubicin,

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

✍ W. K. Hofmann; G. Heil; C. Zander; S. Wiebe; O. G. Ottmann; L. Bergmann; K. Hoef 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 109 KB